Erica Daina Selected Research

Alternative Pathway Complement C3 Convertase

3/2016

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erica Daina Research Topics

Disease

6	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 11/2023 - 03/2012
6	Proteinuria 01/2023 - 02/2010
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2006
4	Kidney Diseases (Kidney Disease) 11/2023 - 02/2010
4	Thrombotic Thrombocytopenic Purpura 02/2009 - 08/2002
3	Atypical Hemolytic Uremic Syndrome 01/2023 - 01/2006
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020 - 01/2019
3	Hemolytic-Uremic Syndrome 01/2006 - 02/2001
2	Glomerulonephritis 12/2023 - 01/2019
1	Hematuria 01/2023
1	Inflammation (Inflammations) 01/2020
1	Chronic Renal Insufficiency 01/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Renal cysts and diabetes syndrome 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Hereditary Nephritis (Alport Syndrome) 01/2015
1	Albuminuria 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Thrombocytopenia (Thrombopenia) 02/2009
1	Anemia 02/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2001

Drug/Important Bio-Agent (IBA)

6	Complement System Proteins (Complement)IBA 01/2023 - 03/2016
6	thiamine triphosphorate (TTP)IBA 02/2009 - 02/2001
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 01/2019
3	eculizumab FDA Link 01/2020 - 03/2012
3	CreatinineIBA 01/2015 - 02/2010
3	ADAMTS13 ProteinIBA 02/2009 - 08/2002
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2020 - 01/2019
2	Complement C3-C5 Convertases (C3 Convertase)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2010
2	Complement Factor H (Factor H)IBA 05/2016 - 02/2001
2	Rituximab (Mabthera)FDA Link 02/2009 - 08/2005
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	danicopanIBA 01/2022
1	Iohexol (Omnipaque)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	ProteomeIBA 01/2019
1	Hepatocyte Nuclear FactorsIBA 01/2019
1	Alternative Pathway Complement C3 ConvertaseIBA 03/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	LipidsIBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	Angiotensin Receptor AntagonistsIBA 01/2015
1	AutoantibodiesIBA 02/2009
1	Shiga Toxin (Shigella Toxin)IBA 01/2006

Therapy/Procedure

5	Therapeutics 12/2023 - 02/2010
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2012
1	Kidney Transplantation 01/2006